{
  "declared_links": {
    "economic_signal_ids": [],
    "relation": "topic-surface-only",
    "scan_signal_ids": []
  },
  "dek": "China has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to sell its orforglipron pill in a market where 630 million adults could be overweight or obese by 2050. GLP-1 drugs aid weight loss by mimicking a natural gut hormone that suppresses appetite and regulates blood sugar levels.",
  "desk": "politics",
  "event_id": "event-342d9a606855005961454ac2",
  "evidence_groups": [
    {
      "group_id": "rthk-editorial",
      "roles": [
        "media"
      ],
      "source_ids": [
        "rthk-greater-china"
      ]
    }
  ],
  "evidence_refs": [
    {
      "independence_group": "rthk-editorial",
      "item_id": "item-a687059cd2ea8f738de16fcb",
      "published_at": "2026-11-13T06:48:10Z",
      "role": "media",
      "source_id": "rthk-greater-china",
      "source_name": "Radio Television Hong Kong",
      "title": "Bitter pill for rivals as Eli Lilly scores China first",
      "url": "https://news.rthk.hk/rthk/en/component/k2/1877688-20261113.htm",
      "version_id": "itemv-af4ce6cc099d7c90b3aabf7d"
    }
  ],
  "evidence_strength": "single-source",
  "headline": "Bitter pill for rivals as Eli Lilly scores China first",
  "lead": false,
  "lead_reason": "Current single-source metadata is retained but not promoted as a lead.",
  "limitations": [
    "Palimpsest retained only feed title, canonical link, time, and a bounded plain-text excerpt; it did not fetch the article body.",
    "The evidence-strength label describes source structure, not truth, intent, impact, or causation.",
    "Declared instrument links are topical pointers until a separate scan or economic observation is joined by time and method.",
    "Title-similarity clustering can miss differently worded or cross-language accounts and can join closely worded updates.",
    "This dossier currently contains one independent evidence group and remains explicitly attributed."
  ],
  "mutation": {
    "kind": "unchanged",
    "previous_version_id": "eventv-5e1a3a82c69bd4ac97ddb35b"
  },
  "published_at": "2026-11-13T06:48:10Z",
  "reported_facts": [
    {
      "attribution": "Radio Television Hong Kong",
      "evidence_item_id": "item-a687059cd2ea8f738de16fcb",
      "published_at": "2026-11-13T06:48:10Z",
      "statement": "Radio Television Hong Kong published “Bitter pill for rivals as Eli Lilly scores China first”."
    }
  ],
  "topics": [
    "economy",
    "politics",
    "rights"
  ],
  "updated_at": "2026-11-13T06:48:10Z",
  "url": "https://palimpsest.info/news/wire/event-342d9a606855005961454ac2/",
  "version_id": "eventv-5e1a3a82c69bd4ac97ddb35b"
}